Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling.
about
Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myelomaSmall compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myelomaCharacterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell deathThe molecular classification of multiple myelomaCharacterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma.The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsMyeloma bone disease: pathophysiology and management.How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow.The role of Dickkopf-1 in bone development, homeostasis, and diseaseSarcosine as a potential prostate cancer biomarker--a reviewBortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors.Molecular mechanisms, current management and next generation therapy in myeloma bone disease.Principled sure independence screening for Cox models with ultra-high-dimensional covariates.Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma.Suboptimal B-cell antigen receptor signaling activity in vivo elicits germinal center counterselection mechanisms.RANKL inhibition: Clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases
P2860
Q28274310-7B729777-205D-4BA0-9BC4-38AD030B01D0Q28478936-1B18FCE1-CBCD-42C6-91D8-101C94742208Q28482928-80004EC8-197D-4D06-ADEC-5192132C56F4Q34530992-E0AF05E7-82A7-411E-AA2F-754A5E2BBA03Q34997270-779102BA-5D4C-40DF-82DC-3C5D783E30A5Q35828711-F92B47A6-FA77-4F5B-9330-040E9B3967B4Q36146493-93B68F75-F58F-4D4B-A649-694502D7EB1DQ36167459-EBA1EA7D-C141-420A-ADBB-0AB2F8FD0F64Q37066218-B101852C-A6C2-4AF6-8136-DB464324C4F0Q37091881-1C2F68FA-1800-492A-B576-ED68B566A6A4Q37176560-10389872-AD92-4985-9EC4-581CFDB3BFBBQ37271048-5734E882-36DD-403D-BD7E-6D537F7946B8Q37591986-A1D0BA16-400D-4C52-AF12-695EDA6CD754Q38749233-AEB8EDAB-3A10-4580-8CC5-F24F66C9C238Q42130229-01B5010C-E481-4986-B741-5C3513753A4BQ45147338-78E5AF20-E4DD-415B-B4E4-C3D46E7C4C22Q54310645-2EFFF0AD-11C0-4B9A-958F-DCE45FDEC29BQ57904702-AFC9FF8B-BCF4-4ACE-A5D5-0F1F8AC33910
P2860
Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interpreting the molecular bio ...... bal gene expression profiling.
@ast
Interpreting the molecular bio ...... bal gene expression profiling.
@en
type
label
Interpreting the molecular bio ...... bal gene expression profiling.
@ast
Interpreting the molecular bio ...... bal gene expression profiling.
@en
prefLabel
Interpreting the molecular bio ...... bal gene expression profiling.
@ast
Interpreting the molecular bio ...... bal gene expression profiling.
@en
P2860
P1476
Interpreting the molecular bio ...... bal gene expression profiling.
@en
P2093
John D Shaughnessy
P2860
P304
P356
10.1034/J.1600-065X.2003.00054.X
P577
2003-08-01T00:00:00Z